Sunscreen Industry Asks FDA For Flexibility Despite Guidances' Rigidity
This article was originally published in The Pink Sheet
Executive Summary
FDA latest sunscreen guidances incorporate little industry input and are met with frustration and hope among industry stakeholders. The PASS Coalition and the Natural Products Association weigh in on future cooperation between FDA and industry under SIA.
You may also be interested in...
FDA Sunscreen Guidance: Absorption Data Is A MUsT For GRASE Review
The agency maintains maximal usage trials are essential in sunscreen ingredient GRASE assessments, despite industry objections that the tests have not been used for UV filters and no protocol is established. FDA’s final guidance closely mirrors its draft issued a year ago, which stakeholders projected would further delay consumer access to updated sunscreen products.
Sunscreen Group Remains Cloudy About FDA's Ingredient Evaluations
PASS Coalition fails to find common ground with US FDA as the sunscreen access advocacy group urges significant changes to a draft guidance on safety testing for sunscreen ingredients.
NPA Asks For Illumination On Draft Guidances For Sunscreen Ingredient Reviews
In response to draft guidances on Sunscreen Innovation Act rules, NPA seeks clarification on GRASE data-submission requirements for combination ingredients and urges more NDAC activity to ensure sunscreen ingredients receive attention and sponsors can comply with SIA timetables.